These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 29158246

  • 1. Self-taken vaginal swabs versus clinician-taken for detection of candida and bacterial vaginosis: a case-control study in primary care.
    Barnes P, Vieira R, Harwood J, Chauhan M.
    Br J Gen Pract; 2017 Dec; 67(665):e824-e829. PubMed ID: 29158246
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of reliability of self-collected vaginal swabs over physician-collected samples for diagnosis of bacterial vaginosis, candidiasis and trichomoniasis, in a resource-limited setting: a cross-sectional study in India.
    Khan Z, Bhargava A, Mittal P, Bharti R, Puri P, Khunger N, Bala M.
    BMJ Open; 2019 Aug 27; 9(8):e025013. PubMed ID: 31462459
    [Abstract] [Full Text] [Related]

  • 3. Clinical Validation of the Aptima Bacterial Vaginosis and Aptima Candida/Trichomonas Vaginitis Assays: Results from a Prospective Multicenter Clinical Study.
    Schwebke JR, Taylor SN, Ackerman R, Schlaberg R, Quigley NB, Gaydos CA, Chavoustie SE, Nyirjesy P, Remillard CV, Estes P, McKinney B, Getman DK, Clark C.
    J Clin Microbiol; 2020 Jan 28; 58(2):. PubMed ID: 31748322
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the BD MAX™ Vaginal Panel for the detection of vaginal infections in a sexual health service in the UK.
    Sherrard J.
    Int J STD AIDS; 2019 Mar 28; 30(4):411-414. PubMed ID: 30931826
    [Abstract] [Full Text] [Related]

  • 5. Prevalence, Associated Factors, and Appropriateness of Empirical Treatment of Trichomoniasis, Bacterial Vaginosis, and Vulvovaginal Candidiasis among Women with Vaginitis.
    Huang SH, Hsu HC, Lee TF, Fan HM, Tseng CW, Chen IH, Shen H, Lee CY, Tai HT, Hsu HM, Hung CC.
    Microbiol Spectr; 2023 Jun 15; 11(3):e0016123. PubMed ID: 37052487
    [Abstract] [Full Text] [Related]

  • 6. The role of physical examination in diagnosing common causes of vaginitis: a prospective study.
    Singh RH, Zenilman JM, Brown KM, Madden T, Gaydos C, Ghanem KG.
    Sex Transm Infect; 2013 May 15; 89(3):185-90. PubMed ID: 23019659
    [Abstract] [Full Text] [Related]

  • 7. Vaginal microbiota of asymptomatic bacterial vaginosis and vulvovaginal candidiasis: Are they different from normal microbiota?
    Pramanick R, Mayadeo N, Warke H, Begum S, Aich P, Aranha C.
    Microb Pathog; 2019 Sep 15; 134():103599. PubMed ID: 31212037
    [Abstract] [Full Text] [Related]

  • 8. Mycobiome Study Reveals Different Pathogens of Vulvovaginal Candidiasis Shape Characteristic Vaginal Bacteriome.
    Zhao C, Li Y, Chen B, Yue K, Su Z, Xu J, Xue W, Zhao G, Zhang L.
    Microbiol Spectr; 2023 Jun 15; 11(3):e0315222. PubMed ID: 36995230
    [Abstract] [Full Text] [Related]

  • 9. Bacterial vaginosis, vulvovaginal candidiasis, and trichomonal vaginitis in reproductive-age women in Yunnan, China: a descriptive study.
    Zhao T, Xiao X, Xiao L, Wu XM, Yuan T.
    J Obstet Gynaecol; 2022 Oct 15; 42(7):3187-3192. PubMed ID: 35947028
    [Abstract] [Full Text] [Related]

  • 10. Correlation Analysis of Vaginal Microbiome Changes and Bacterial Vaginosis Plus Vulvovaginal Candidiasis Mixed Vaginitis Prognosis.
    Xiao B, A D, Qin H, Mi L, Zhang D.
    Front Cell Infect Microbiol; 2022 Oct 15; 12():860589. PubMed ID: 35372135
    [Abstract] [Full Text] [Related]

  • 11. Impact of Lactobacillus crispatus-containing oral and vaginal probiotics on vaginal health: a randomised double-blind placebo controlled clinical trial.
    Mändar R, Sõerunurk G, Štšepetova J, Smidt I, Rööp T, Kõljalg S, Saare M, Ausmees K, Le DD, Jaagura M, Piiskop S, Tamm H, Salumets A.
    Benef Microbes; 2023 Apr 18; 14(2):143-152. PubMed ID: 36856121
    [Abstract] [Full Text] [Related]

  • 12. Neutrophil Gelatinase-Associated Lipocalin Concentration in Vaginal Fluid: Relation to Bacterial Vaginosis and Vulvovaginal Candidiasis.
    Beghini J, Giraldo PC, Linhares IM, Ledger WJ, Witkin SS.
    Reprod Sci; 2015 Aug 18; 22(8):964-8. PubMed ID: 25670719
    [Abstract] [Full Text] [Related]

  • 13. Interpretation of vaginal metagenomic characteristics in different types of vaginitis.
    Song J, Dong X, Lan Y, Lu Y, Liu X, Kang X, Huang Z, Yue B, Liu Y, Ma W, Zhang L, Yan H, He M, Fan Z, Guo T.
    mSystems; 2024 Mar 19; 9(3):e0137723. PubMed ID: 38364107
    [Abstract] [Full Text] [Related]

  • 14. Bacterial vaginosis, vulvovaginal candidiasis and trichomonal vaginitis among reproductive-aged women seeking primary healthcare in Sana'a city, Yemen.
    Abdul-Aziz M, Mahdy MAK, Abdul-Ghani R, Alhilali NA, Al-Mujahed LKA, Alabsi SA, Al-Shawish FAM, Alsarari NJM, Bamashmos W, Abdulwali SJH, Al Karawani M, Almikhlafy AA.
    BMC Infect Dis; 2019 Oct 22; 19(1):879. PubMed ID: 31640583
    [Abstract] [Full Text] [Related]

  • 15. Clinical Validation of a Test for the Diagnosis of Vaginitis.
    Gaydos CA, Beqaj S, Schwebke JR, Lebed J, Smith B, Davis TE, Fife KH, Nyirjesy P, Spurrell T, Furgerson D, Coleman J, Paradis S, Cooper CK.
    Obstet Gynecol; 2017 Jul 22; 130(1):181-189. PubMed ID: 28594779
    [Abstract] [Full Text] [Related]

  • 16. Leukocyte esterase activity in vaginal fluid of pregnant and non-pregnant women with vaginitis/vaginosis and in controls.
    Mårdh PA, Novikova N, Niklasson O, Bekassy Z, Skude L.
    Infect Dis Obstet Gynecol; 2003 Jul 22; 11(1):19-26. PubMed ID: 12839629
    [Abstract] [Full Text] [Related]

  • 17. Treatment considerations for bacterial vaginosis and the risk of recurrence.
    Chen JY, Tian H, Beigi RH.
    J Womens Health (Larchmt); 2009 Dec 22; 18(12):1997-2004. PubMed ID: 20044862
    [Abstract] [Full Text] [Related]

  • 18. Clinical characteristics of aerobic vaginitis and its association to vaginal candidiasis, trichomonas vaginitis and bacterial vaginosis.
    Jahic M, Mulavdic M, Nurkic J, Jahic E, Nurkic M.
    Med Arch; 2013 Dec 22; 67(6):428-30. PubMed ID: 25568514
    [Abstract] [Full Text] [Related]

  • 19. Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial.
    Marrazzo JM, Dombrowski JC, Wierzbicki MR, Perlowski C, Pontius A, Dithmer D, Schwebke J.
    Clin Infect Dis; 2019 Feb 15; 68(5):803-809. PubMed ID: 30184181
    [Abstract] [Full Text] [Related]

  • 20. Detection of bacterial vaginosis, Trichomonas vaginalis infection, and vaginal Candida infection: a comparative study of methods of extracting exudates, with and without a speculum, during pregnancy.
    Audisio T, Penacino M, Cannistraci R, Bertolotto P.
    J Low Genit Tract Dis; 2005 Oct 15; 9(4):213-5. PubMed ID: 16205190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.